All > Bc Prostate Cancer > Vancouver

Pharmacist-led HFrEF medication optimization for Heart Failure with Reduced Ejection Fraction

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
St. Paul's Hospital, Vancouver, CanadaHeart Failure with Reduced Ejection FractionPharmacist-led HFrEF medication optimization - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if a remote pharmacist-led intervention can improve medication use in people with HFrEF.

Eligible Conditions
  • Heart Failure with Reduced Ejection Fraction

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
XXB750
1
LY3461767
1
Pharmacist-led deprescribing

Study Objectives

3 Primary · 6 Secondary · Reporting Duration: month 12

Baseline
Feasibility of recruitment
month 12
Feasibility of patient-reported outcome measure (PROM) collection & participant retention
Medication adherence
Medication adverse effects
Optimization of HFrEF medications
Quality of life: 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
Treatment burden
Treatment satisfaction
month 6
Feasibility of achieving rapid optimal medical therapy in intervention arm

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
XXB750
1
LY3461767
1
Pharmacist-led deprescribing

Trial Design

1 Treatment Group

Pharmacist-led HFrEF medication optimization
1 of 1

Experimental Treatment

60 Total Participants · 1 Treatment Group

Primary Treatment: Pharmacist-led HFrEF medication optimization · No Placebo Group · N/A

Pharmacist-led HFrEF medication optimizationExperimental Group · 2 Interventions: Pharmacist-led HFrEF medication optimization, Usual care · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: month 12

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,335 Previous Clinical Trials
1,552,745 Total Patients Enrolled
University of AlbertaOTHER
823 Previous Clinical Trials
377,153 Total Patients Enrolled
Ricky Turgeon, BSc(Pharm), ACPR, PharmDPrincipal InvestigatorUniversity of British Columbia

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are willing to take medication to treat heart failure with reduced ejection fraction (HFrEF).
References

Frequently Asked Questions

Are medical professionals currently accepting participants for this trial?

"As per clinicaltrials.gov, this investigation is still looking to enrol participants. The trial was established on March 13th 2023 and amended most recently on the 9th of that same month." - Anonymous Online Contributor

Unverified Answer

What is the total number of volunteers taking part in this experiment?

"Affirmative. According to clinicaltrials.gov, this research is currently recruiting patients who meet its inclusion criteria. The initial posting date was March 13th 2023 and the listing has been up-to-date as of March 9th 2023. 60 volunteers are being sought from a single trial site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top